Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lai

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Best Practice & Research. Clinical Haematology|June 18, 2013
T-cell lymphomaCatherine Lai, Wyndham Wilson
Oncology (Williston Park, N.Y.)|March 8, 2012
Nodal marginal zone lymphoma: impersonalized medicineCatherine Lai, Mark Roschewski
Leukemia & Lymphoma|October 27, 2012
Tackling Burkitt lymphoma in older patients: novel strategies and the promise of targeted agentsCatherine Lai, Kieron Dunleavy
Best Practice & Research. Clinical Haematology|June 18, 2013
NK/T-cell lymphomas in childrenCatherine Lai, Kieron Dunleavy
Blood Advances|March 13, 2026
Does age matter? Optimizing AML treatment in older adultsCatherine Lai, Tara L Lin
Journal of Hematology & Oncology|September 20, 2019
Recent drug approvals for acute myeloid leukemiaCatherine Lai, Kimberley Doucette, Kelly Norsworthy
Leukemia & Lymphoma|September 18, 2013
Interpreting MYC and BCL2 in diffuse large B-cell lymphomaCatherine Lai, Cliona Grant, Kieron Dunleavy
Clinical Advances in Hematology & Oncology : H&O|June 22, 2022
Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?Nikitha Vobugari, Cambria Heuston, Catherine Lai
Therapeutic Advances in Hematology|May 17, 2021
Advances in therapeutic options for newly diagnosed, high-risk AML patientsKimberley Doucette, Judith Karp, Catherine Lai
Blood and Lymphatic Cancer : Targets and Therapy|December 19, 2019
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin LymphomaCatherine Lai, Adrese Michael Kandahari, Chaitra Ujjani
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Best Practice & Research. Clinical Haematology|June 18, 2013
T-cell lymphomaCatherine Lai, Wyndham Wilson
Oncology (Williston Park, N.Y.)|March 8, 2012
Nodal marginal zone lymphoma: impersonalized medicineCatherine Lai, Mark Roschewski
Leukemia & Lymphoma|October 27, 2012
Tackling Burkitt lymphoma in older patients: novel strategies and the promise of targeted agentsCatherine Lai, Kieron Dunleavy
Best Practice & Research. Clinical Haematology|June 18, 2013
NK/T-cell lymphomas in childrenCatherine Lai, Kieron Dunleavy
Blood Advances|March 13, 2026
Does age matter? Optimizing AML treatment in older adultsCatherine Lai, Tara L Lin
Journal of Hematology & Oncology|September 20, 2019
Recent drug approvals for acute myeloid leukemiaCatherine Lai, Kimberley Doucette, Kelly Norsworthy
Leukemia & Lymphoma|September 18, 2013
Interpreting MYC and BCL2 in diffuse large B-cell lymphomaCatherine Lai, Cliona Grant, Kieron Dunleavy
Clinical Advances in Hematology & Oncology : H&O|June 22, 2022
Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?Nikitha Vobugari, Cambria Heuston, Catherine Lai
Therapeutic Advances in Hematology|May 17, 2021
Advances in therapeutic options for newly diagnosed, high-risk AML patientsKimberley Doucette, Judith Karp, Catherine Lai
Blood and Lymphatic Cancer : Targets and Therapy|December 19, 2019
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin LymphomaCatherine Lai, Adrese Michael Kandahari, Chaitra Ujjani
Pageof 9